Rituximab +/- Bevacizumab in the Treatment of Patients With Follicular Non-Hodgkin's Lymphoma: A Randomized, Phase II Trial.
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2015
At a glance
- Drugs Bevacizumab (Primary) ; Rituximab
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 01 Aug 2014 Interim results published in the Clinical Lymphoma, Myeloma & Leukemia.
- 13 Feb 2014 Planned End Date changed from 1 Dec 2013 to 1 Jun 2014, as per ClinicalTrials.gov record.
- 10 Dec 2012 Results presented at the 54th Annual Meeting and Exposition of the American Society of Hematology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History